<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50659">Dronedarone</z:chebi>, a recently approved antiarrhythmic drug, has been shown to have fewer side effects than <z:chebi fb="0" ids="2663">amiodarone</z:chebi>, particularly with regard to thyroid and neurologic events </plain></SENT>
<SENT sid="1" pm="."><plain>Since the effects of either drug on ventricular defibrillation threshold during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> are unknown, the aim of this study was to compare the effects of <z:chebi fb="0" ids="50659">dronedarone</z:chebi> and <z:chebi fb="0" ids="2663">amiodarone</z:chebi> on defibrillation efficacy during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in a closed-chest animal model </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50659">Dronedarone</z:chebi> (30 mg·kg·d) and <z:chebi fb="0" ids="2663">amiodarone</z:chebi> (20 mg·kg·d) were administered orally for 3 weeks to 19 and 21 pigs, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>A control group (no treatment) comprised 19 pigs </plain></SENT>
<SENT sid="4" pm="."><plain>A 2-lead endovascular defibrillation system was used </plain></SENT>
<SENT sid="5" pm="."><plain>Each biphasic shock was delivered after 8 seconds of <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>A step-up/step-down protocol was used to calculate mean defibrillation threshold before and 10 minutes after coronary <z:mp ids='MP_0006134'>artery occlusion</z:mp> using an angioplasty balloon in the left descending artery </plain></SENT>
<SENT sid="7" pm="."><plain>At basal state, defibrillation threshold did not differ between the control (20.8 ± 4.8 J), <z:chebi fb="0" ids="2663">amiodarone</z:chebi> (21.2 ± 2 J), and <z:chebi fb="0" ids="50659">dronedarone</z:chebi> (19.5 ± 3 J) groups </plain></SENT>
<SENT sid="8" pm="."><plain>After <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the <z:chebi fb="0" ids="2663">amiodarone</z:chebi> group had a significantly higher defibrillation threshold than the control group (29.6 ± 3 J vs. 21.8 ± 5 J, respectively; P = 0.015), but the <z:chebi fb="0" ids="50659">dronedarone</z:chebi> (22.8 ± 4 J) and control groups had similar defibrillation threshold values </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate that oral <z:chebi fb="0" ids="50659">dronedarone</z:chebi> treatment, unlike oral <z:chebi fb="0" ids="2663">amiodarone</z:chebi>, does not affect defibrillation threshold during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in pigs </plain></SENT>
</text></document>